Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ABSTRACT


01 febrero 2013

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Transarterial Chemoembolization with Additional Cisplatin Infusion for Hepatocellular Carcinoma Invading the Hepatic Vein

Hyo-Cheol Kim, MD , Jeong-Hoon Lee, MD , Jin Wook Chung, MD , Beomsik Kang, MD , Jung-Hwan Yoon, MD , Yoon Jun Kim, MD , Hyo-Suk Lee, MD , Hwan Jun Jae, MD , Jae Hyung Park, MD

Purpose: To evaluate retrospectively the efficacy of transarterial chemoembolization in patients with hepatocellular carcinoma (HCC) with hepatic vein invasion by comparing the results of conventional transarterial chemoembolization and modified transarterial chemoembolization.

01 febrero 2013

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Factors Affecting Survival following Chemoembolization with Doxorubicin-eluting Microspheres for Inoperable Hepatocellular Carcinoma

Sanjeeva P. Kalva, MD , Melina Pectasides, MD , Kalpana Yeddula, MD , Suvranu Ganguli, MD , Lawrence S. Blaszkowsky, MD , Andrew X. Zhu, MD

Purpose: To assess factors associated with better overall survival (OS) and progression-free survival (PFS) following chemoembolization with doxorubicin-eluting microspheres for inoperable hepatocellular carcinoma (HCC)

01 febrero 2013

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Percutaneous Cryoablation of Musculoskeletal Oligometastatic Disease for Complete Remission

Brendan P. McMenomy, MD , A. Nicholas Kurup, MD , Geoffrey B. Johnson, MD, PhD , Rickey E. Carter, PhD , Robert R. McWilliams, MD , Svetomir N. Markovic, MD, PhD , Thomas D. Atwell, MD , Grant D. Schmit, MD , Jonathan M. Morris, MD , David A. Woodrum, MD , Adam J. Weisbrod, MD , Peter S. Rose, MD , Matthew R. Callstrom, MD, PhD

Purpose: To assess the safety and effectiveness of percutaneous cryoablation to treat limited metastases to the musculoskeletal system, with the goal of complete disease remission.

01 diciembre 2012

AMERICAN JOURNAL OF ROENTGENOLOGY. Effectiveness, Safety, and Local Progression After Percutaneous Laser Ablation for Hepatocellular Carcinoma Nodules up to 4 cm Are Not Affected by Tumor Location

Giampiero Francica, Alessandra Petrolati, Enrico Di Stasio, Sara Pacella, Roberto Stasi and Claudio Maurizio Pacella

OBJECTIVE. A high-risk location—defined as the tumor margin being less than 5 mm from large vessels or vital structures—represents a well-known limitation and contraindication for radiofrequency ablation of hepatocellular carcinoma (HCC) nodules. The aim of this study was to verify whether HCC nodule location negatively affected the outcome of percutaneous laser ablation in terms of its primary effectiveness, safety, and ability to prevent local tumor progression.

01 diciembre 2012

AMERICAN JOURNAL OF ROENTGENOLOGY. Fotemustine Chemoembolization of Hepatic Metastases From Uveal Melanoma: A Retrospective Single-Center Analysis

Gundula Edelhauser, Nikolaus Schicher, Dominik Berzaczy, Dietrich Beitzke, Christoph HöelleR, Johannes Lammer and Martin Funovics

OBJECTIVE. The purpose of the current study was to retrospectively evaluate response and survival in patients with hepatic metastasis from uveal melanoma treated by palliative transarterial chemoembolization (TACE) with fotemustine.

01 diciembre 2013

AMERICAN JOURNAL OF ROENTGENOLOGY. Polytetrafluoroethylene-Covered Retrievable Expandable Nitinol Stents for Malignant Esophageal Obstructions: Factors Influencing the Outcome of 270 Patients

Jung-Hoon Park, Ho-Young Song, Jin Hyoung Kim, Hwoon-Yong Jung, Jong-Hoon Kim, Sung-Bae Kim and Heuiran Lee4

OBJECTIVE. The purpose of this study was to evaluate the clinical effectiveness of polytetrafluoroethylene (PTFE)–covered retrievable expandable nitinol stents in patients with malignant esophageal strictures and to identify prognostic factors associated with clinical outcomes.

01 enero 2013

JOURNAL OF HEPATOLOGY. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: Analysis of prognostic factors

Young-sun Kim , Hyo Keun Lim , Hyunchul Rhimemail address , Min Woo Lee , Dongil Choi , Won Jae Lee , Seung Woon Paik , Kwang Cheol Koh , Joon Hyeok Lee , Moon Seok Choi , Geum-Youn Gwak , Byung Chul Yoo

Background & Aims: The aim was to assess 10-year outcomes of radiofrequency ablation as a first-line therapy of early-stage hepatocellular carcinoma with an analysis of prognostic factors.

01 diciembre 2012

JOURNAL OF HEPATOLOGY. Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma

Myeong Jun Song , Ho Jong Chun , Do Seon Song , Hee Yeon Kim , Sun Hong Yoo , Chung-Hwa Park , Si Hyun Bae , Jong Young Choi , U Im Chang , Jin Mo Yang , Hae Giu Lee , Seung Kew Yoon

Background & Aims: Transarterial chemoembolization (TACE) is a widely used treatment for hepatocellular carcinoma. In order to maximize its therapeutic efficacy, doxorubicin-loaded drug-eluting beads have been developed to deliver higher doses of the chemotherapeutic agent and to prolong contact time with the tumor. The purpose of this study was to evaluate the efficacy and safety of drug-eluting bead (DC bead®) TACE in comparison with conventional TACE (cTACE).

01 febrero 2013

RADIOLOGY. Percutaneous Recanalization for Budd-Chiari Syndrome: An 11-year Retrospective Study on Patency and Survival in 177 Chinese Patients from a Single Center

Guohong Han, MD, Xingshun Qi, MD, Wei Zhang, MD, Chuangye He, MD, Zhanxin Yin, MD, Jianhong Wang, MD, Jielai Xia, MD, Ke Xu, MD, Wengang Guo, MD, Jing Niu, MD, Kaichun Wu, MD, PhD and Daiming Fan, MD, PhD

Purpose: To evaluate the long-term outcomes of percutaneous recanalization and determine the predictors of patency and survival in a large case series of Chinese patients with Budd-Chiari syndrome (BCS).

01 enero 2013

AMERICAN JOURNAL OF ROENTGENOLOGY. Transjugular Intrahepatic Portosystemic Shunts in Liver Transplant Recipients: Technical Analysis and Clinical Outcome

Wael E. A. Saad, Wael M. Darwish, Mark G. Davies, Sean Kumer, Curtis Anderson, David L. Waldman, Timothy Schmitt, Alan H. Matsumoto and John F. Angle

OBJECTIVE. The purpose of this study is to compare the technical success of transjugular intrahepatic portosystemic shunt (TIPS) in transplanted versus nontransplanted livers and to assess the clinical outcome of TIPS in liver transplant recipients.

01 febrero 2013

EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a meta-analysis of randomized-controlled trials

Lu, Zaiming; Wen, Feng; Guo, Qiyong; Liang, Hongyuan; Mao, Xiaonan; Sun, Hongzan

Background: There is a continuing debate on whether transcatheter arterial chemoembolization (TACE) plus radiofrequency ablation (RFA) is more effective than RFA alone in the treatment of patients with hepatocellular carcinoma (HCC). We carried out this meta-analysis of randomized-controlled trials to provide greater clarity on whether RFA plus TACE was more effective than RFA alone for HCC.

01 diciembre 2012

JOURNAL OF HEPATOLOGY. Response rate and clinical outcome of HCC after first and repeated cTACE performed “on demand”

E. Terzi , R. Golfieri , F. Piscaglia , M. Galassi , A. Dazzi , S. Leoni , E. Giampalma , M. Renzulli , L. Bolondie

Background & Aims: Aim of the study was to assess the clinical impact of conventional transarterial chemoembolization (cTACE) repeated “on demand” on HCC outcome. Outcome measures were: response rate to first and repeated cTACE, recurrence rates and overall survival.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.